A case ofGuillain-Barre syndrome following meningococcal meningitis is reported. The diagnosis was made on clinical grounds and the results of electrophysiological studies. The patient recovered spontaneously. Guillain-Barr6 syndrome following meningococcal infection has not to our knowledge been reported previously.
Introduction
Meningococcal meningitis accounts for up to 40°/, of all cases of purulent meningitis.' The neurological complications of this variety of meningitis are various (see box).2-5 About twothirds of patients with Guillain-Barre syndrome (GBS) have a preceding infection or an antecedent event a few weeks prior to neuropathy. There are scattered reports of GBS associated with Gram-negative bacterial infections. 6 To the best of our knowledge there is no published report of GBS after meningococcal infection. We now report such a case.
Case
An 11-year-old boy was can cause mononeuropathy or brachial plexopathy. However, chloramphenicol produces painful sensorimotor polyneuropathy usually accompanied by optic neuropathy and only after prolonged and high dosage.8 Although both penicillin and chloramphenicol were used in this case, the pattern ofneuropathy was quite different from the ones described with these drugs.
Critically ill polyneuropathy is a sensorimotor polyneuropathy with an onset in the fifth decade and occurrence at the peak of critical illness.9 The electrophysiological characteristics of this type of neuropathy are of the axonal type, ie, reduced amplitude of compound motor and sensory nerve action potential and near normal motor and sensory conduction velocities, along with normal F-wave latency and denervation pattern on needle electromyogram. The patient was seriously ill but did not meet the criteria, either clinical or electophysiological, described for critically ill polyneuropathy.
The electrophysiological findings in this case were as described for peripheral demyelinative neuropathy.'0 Up to 90% of individuals with GBS may have some electrophysiological abnormality within the first two weeks of illness, eg, partial conduction block or decreased amplitude of compound motor action potential or both (75%), prolonged distal latency (33%), slowed conduction velocity (20%), and temporal dispersion (20%), while by three weeks 96% have abnormalities. Abnormal F response either absent or prolonged, reflecting involvement of proximal nerve segment may occur in up to 46% of patients studied in the first month." Pathophysiological correlations in GBS have revealed conduction block as an early abnormality, usually occuring before slowing of nerve conduction.'2 The clinical weakness is directly related to the number of nerve fibres showing conduction block. The slowed conduction velocity which is thought to be a feature of demyelination may perhaps be due to remyelination. In GBS, especially during the first week of illness when the demyelinative process is at a peak, the conduction velocity may be within normal limits, whereas in hereditary and chronic demyelinative neuropathies when the clinical weakness is improving the conduction velocity may be markedly slowed. Our patient had both clinical weakness and altered electrophysiology of motor nerves. The clinical profile was that described for GBS."
Various meningococcal-induced autoimmune disorders have multi-organ immune complex deposition.'3 The occurrence of peripheral neuropathy within two weeks ofmeningococcal infection points toward there being a relationship between these events rather than a mere coincidence. This latent period is perhaps due to the time taken for the immune process initiation and manifestation. Thus, this patient appears unique in having GBS following meningococcal meningitis.
